Functional Residual Capacity (FRC) Does Not Predict Response to Surfactant in Preterm Infants

ABSTRACT

We tested the hypothesis that the initial functional residual capacity (FRC) of preterm infants with hyaline membrane disease (HMD) could predict the response to surfactant replacement (Survanta, 4 mL/kg/dose), with a better initial FRC being correlated with a greater improvement in PaO₂, a/A PO₂ ratio, and FRC. Thirty-four preterm infants were studied on 41 occasions. FRC and arterial blood gases were measured immediately prior to treatment. FRC was measured by the helium dilution method. Arterial blood gases were measured again after 30, 60, and 120 minutes. FRC was measured after 120 minutes. Twenty-seven treatments resulted in an increase in PaO₂ >10 mmHg (responders); 14 did not (nonresponders). There was no correlation between initial FRC, change in FRC, and change in PaO₂ (r ² = 0.07). These results suggest that there is no relationship between initial FRC and response to surfactant treatment.

FRC - arterial/alveolar PO₂ ratio - surfactant replacement - hyaline membrane disease - preterm infants

REFERENCES

• 1 Avery M E, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease.  Am J Dis Child . 1959;  97 517-523
• 2 Auld P AM, Nelson N M, Cherry R B, Rudolph A J, Smith C A. Measurement of thoracic gas volume in the newborn infant.  J Clin Invest . 1963;  42 476-483
• 3 Gribetz I, Frank N R, Avery M E. Static volume-pressure relations of excised lungs of infants with hyaline membrane disease of the newborn infant.  J Clin Invest . 1959;  38 2168-2175
• 4 Gruenwald P. Normal and abnormal expansion of the lungs of newborn infants obtained at autopsy: II. Opening pressure, maximal volume, and stability of expansion.  Lab Invest . 1963;  12 563-576
• 5 Karlberg P, Cook C D, O'Brien D, Cherry R B, Smith C A. Studies of respiratory physiology in the newborn infant: observations during and after respiratory distress.  Acta Paediatr . 1954;  43(Suppl 100) 397-411
• 6 Tori C A, Krauss A N, Auld P AM. Serial studies of lung volume and VA/Q in hyaline membrane disease.  Pediatr Res . 1973;  7 82-88
• 7 Krauss A N, Auld P AM. Measurement of functional residual capacity in distressed neonates by helium rebreathing.  J Pediatrics . 1970;  77 228-232
• 8 Kwong M S, Egan E A, Notter R H, Shapiro D L. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.  Pediatrics . 1985;  76 585-592
• 9 Kendig J W, Notter R H, Cox C. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparison with similar trials.  Pediatrics . 1988;  82 756-762
• 10 Bose C, Corbet A, Bose G. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.  J Pediatr . 1990;  117 947-953
• 11 Merritt T A, Hallman M, Berry C. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants.  J Pediatr . 1991;  118 581-594
• 12 Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome.  J Pediatr . 1991;  118 595-605
• 13 Charon A, Taeusch H W, Fitzgibbon C, Smith G B, Treves S T, Phelps D S. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.  Pediatrics . 1989;  83 348-354
• 14 Wallenbrock M A, Sekar K C, Toubas P L. Prediction of the acute response to surfactant by pulmonary function testing.  Pediatr Pulmonol . 1992;  13 11-15
• 15 Krauss A N, Auld P AM. Pulmonary gas trapping in premature infants.  Pediatr Res . 1971;  5 10-16
• 16 Gilbert R, Keighley J F. The arterial/alveolar oxygen tension ratio: an index of gas exchange applicable to varying inspired oxygen concentrations.  Am Rev Resp Dis . 1974;  109 142-145
• 17 Bowen W, Martin C R, Krauss A N, Auld P AM. Ventilation-perfusion relationships in preterm infants after surfactant treatment.  Pediatr Pulmonol . 1994;  18 155-162
• 18 Croxton F E. Elementary Statistics with Applications in Medicine and the Biological Science.  New York: Dover Publications 1959
• 19 Sandberg K, Edberg K E, Benton W W, Silberberg A, Sladek M, Sundell H W. Surfactant improves gas mixing and alveolar ventilation in preterm lambs.  Pediatr Res . 1991;  30 181-189
• 20 Vilstrup C, Gommers D, Bos J AH, Lachmann B, Werner O, Larsson A. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.  Pediatr Res . 1992;  32 595-599
• 21 Bambang Oetomo S, Reijngoud D-J, Ennemb J J, Okken A, Wildebur C RH. Surfactant replacement therapy in surfactant deficient rabbits: early effects on lung function and biochemical aspects.  Lung . 1988;  166 65-73
• 22 Cotton R B, Olsson T, Law A B. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.  Pediatr Res . 1993;  34 495-501
• 23 Edberg K E, Ekstrom-Jodal B, Hallman M, Hjalmarson O, Sandberg K, Silberberg A. Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS.  Acta Paediatr Scand . 1990;  79 750-755
• 24 Farhi L E. Ventilation-perfusion relationship and its role in alveolar gas exchange. In: Caro CG, ed. Advances in Respiratory Physiology Baltimore: Williams and Wilkins 1966: 148-197
• 25 West J B. Ventilation/Blood Flow and Gas Exchange.  5th ed. Oxford, England: Blackwell Scientific Publications 1990: 80-94
• 26 Krauss A N, Auld P AM. Ventilation-perfusion abnormalities in the premature infant: triple gradient.  Pediatr Res . 1969;  3 255-264
• 27 Hand I L, Shepard E K, Krauss A N, Auld P AM. Ventilation-perfusion abnormalities in the preterm infant with hyaline membrane disease: a two-compartment model of the neonatal lung.  Pediatr Pulmonol . 1990;  9 206-213